Influence of psychiatric disorders in patients treated with Varenicline.

N. Fouz Rosón (Barcelona, Spain)

Source: International Congress 2017 – Smoking cessation treatment and e-cigarettes
Session: Smoking cessation treatment and e-cigarettes
Session type: Poster Discussion
Number: 4478
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Fouz Rosón (Barcelona, Spain). Influence of psychiatric disorders in patients treated with Varenicline.. 4478

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Withdrawal symptoms in psychiatric patients treated with varenicline
Source: Annual Congress 2008 - Smoking cessation and new tobacco uses
Year: 2008


Prevalence of psychiatric disorders in seriously-ill COPD patients
Source: Annual Congress 2008 - COPD epidemiology
Year: 2008


Treatment of comorbid insomnia disorder: implications for somatic and mental health
Source: Sleep and Breathing Conference 2021
Year: 2021


Problems of treatment of TB patients suffering from alcohol and drugs addiction
Source: Eur Respir J 2002; 20: Suppl. 38, 369s
Year: 2002

Prevalence of psychiatric disorders in patients undergoing specific challenge tests for the diagnosis of occupational asthma
Source: Annual Congress 2008 - Occupational asthma - agents and management
Year: 2008

Peculiar properties of sleep structure and impact of antidepressive therapy in COPD patients with concomitant depressive episode
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013


DOTS-Plus treatment of MDR-TB patients with psychiatric disorders
Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care
Year: 2007


Effectiveness of smoking cessation in patients with psychiatric disease
Source: Annual Congress 2012 - Tobacco comorbidity
Year: 2012


Treatment of narcolepsy and comorbid conditions
Source: Sleep and Breathing Conference 2021
Year: 2021


Longitudinal impact of depressive disorders on asthma control in adult patients
Source: International Congress 2017 – Clinical points to ponder in asthma
Year: 2017


Incidence of asthma in patients with attention deficit hyperactivity disorder (ADHD)
Source: Annual Congress 2005 - What is new in childhood respiratory epidemiology?
Year: 2005


The effects of anxiety and depression on treatment adherence in COPD patients
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010


Effects of CPAP treatment on anxiety and depression in patients with OSAS
Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment
Year: 2017


Influence of COVID-19 pneumonia on development of mental disorders
Source: Virtual Congress 2021 – Long COVID - 19
Year: 2021


Role and management of COPD concomitant disorders
Source: Annual Congress 2010 - GOLD Update
Year: 2010


Acute psychosis after CPAP treatment in a schizophrenic patient with sleep apnoea{-}hypopnoea syndrome
Source: Eur Respir J 2001; 17: 313-315
Year: 2001



Smoking status and levels of anxiety and depression in hospitalized patients.
Source: International Congress 2018 – Effect of tobacco use on health
Year: 2018

Clinical effectiveness of antidepressive drug in patients with COPD and concomitant moderate depressive episode
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013


Psychiatric disorders in COPD patients
Source: Annual Congress 2012 - COPD comorbidities I
Year: 2012